Profil
Kevin Chaplin has held positions as CEO at Kardium, Inc. since 2008 and as Director at LifeSciences British Columbia since 2021.
Postes actifs de Kevin Chaplin
| Sociétés | Poste | Début |
|---|---|---|
Kardium, Inc.
 Kardium, Inc. Medical SpecialtiesHealth Technology Kardium, Inc. develops groundbreaking medical devices. It offers treatment for atrial fibrillation. The company was founded by Dan Gelbart in 2007 and is headquartered in Burnaby, Canada. | Directeur Général | 01/01/2008 |
LifeSciences British Columbia
 LifeSciences British Columbia BiotechnologyHealth Technology LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada. | Directeur/Membre du Conseil | 16/09/2021 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Kardium, Inc.
Kardium, Inc. Medical SpecialtiesHealth Technology Kardium, Inc. develops groundbreaking medical devices. It offers treatment for atrial fibrillation. The company was founded by Dan Gelbart in 2007 and is headquartered in Burnaby, Canada. | Health Technology |
LifeSciences British Columbia
LifeSciences British Columbia BiotechnologyHealth Technology LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada. | Health Technology |